Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Infect Chemother ; 30(6): 548-551, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38042300

RESUMO

A 28-year old Japanese man with Noonan syndrome (NS) presented to our emergency department with painful erythema of the trunk and lower extremities since the previous day. He had been diagnosed with protein-losing enteropathy (PLE) with intestinal lymphangiectasia at age 25 years, and undergone lymphaticovenular anastomosis (LVA) twice. Three episodes of cellulitis of both lower extremities had occurred in the past 2 years. Extensive cellulitis with sepsis was diagnosed and piperacillin/tazobactam was started, which was de-escalated to ceftriaxone. He was discharged after 13 days of antibiotic therapy. After discharge, low-dose trimethoprim-sulfamethoxazole (SMZ-TMP) was started as the primary prophylaxis, but three episodes of cellulitis occurred in the next year and were treated with other antibiotics. NS, an autosomal dominant disease known as a RASopathy, is caused by germline mutations in RAS-MAPK pathway genes. Lymphedema resulting from lymphatic abnormalities is a concomitant manifestation in 20 % of patients with NS, and can be a risk factor for cellulitis. Hypoalbuminemia and hypoglobulinemia associated with PLE facilitate infections such as cellulitis. As a treatment for lymphedema in the extremities, LVA has shown objective and subjective improvements in most patients, and some studies have also reported its efficacy for lymphedema in patients with NS. Targeted molecular therapy with mitogen-activated protein kinase enzyme (MEK) inhibitor is used in treatment of cancers with activation of the RAS/MAPK pathway. MEK inhibitors have recently been tried in patients with RASopathies and severe lymphatic disorders, and can lead to rapid resolution of symptoms.

2.
Biosci Biotechnol Biochem ; 81(6): 1185-1193, 2017 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-28485211

RESUMO

6-Tuliposide B (PosB) is a glucose ester accumulated in tulip (Tulipa gesneriana) as a major secondary metabolite. PosB serves as the precursor of the antimicrobial lactone tulipalin B (PaB), which is formed by PosB-converting enzyme (TCEB). The gene TgTCEB1, encoding a TCEB, is transcribed in tulip pollen but scarcely transcribed in other tissues (e.g. roots) even though those tissues show high TCEB activity. This led to the prediction of the presence of a TCEB isozyme with distinct tissue specificity. Herein, we describe the identification of the TgTCEB-R gene from roots via native enzyme purification; this gene is a paralog of TgTCEB1. Recombinant enzyme characterization verified that TgTCEB-R encodes a TCEB. Moreover, TgTCEB-R was localized in tulip plastids, as found for pollen TgTCEB1. TgTCEB-R is transcribed almost exclusively in roots, indicating a tissue preference for the transcription of TCEB isozyme genes.


Assuntos
Hidrolases de Éster Carboxílico/genética , Regulação da Expressão Gênica de Plantas , Glucosídeos/metabolismo , Hidroxibutiratos/metabolismo , Proteínas de Plantas/genética , Raízes de Plantas/enzimologia , Tulipa/enzimologia , 4-Butirolactona/análogos & derivados , 4-Butirolactona/metabolismo , Sequência de Aminoácidos , Anti-Infecciosos/metabolismo , Biotransformação , Hidrolases de Éster Carboxílico/metabolismo , Clonagem Molecular , Escherichia coli/genética , Escherichia coli/metabolismo , Expressão Gênica , Isoenzimas/genética , Isoenzimas/metabolismo , Cinética , Especificidade de Órgãos , Proteínas de Plantas/metabolismo , Raízes de Plantas/genética , Pólen/enzimologia , Pólen/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Metabolismo Secundário/genética , Especificidade por Substrato , Transcrição Gênica , Tulipa/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...